Vasculoprotective Effects of Combined Endothelial Progenitor Cells and Mesenchymal Stem Cells in Diabetic Wound Care: Their Potential Role in Decreasing Wound-Oxidative Stress
Figure 5
The tissue malondialdehyde levels (MDA) in the control group with implanted fibrin gel (control), diabetic wound group with implanted fibrin gel (DM), diabetic wound group with implanted fibrin gel and MSCs (DM + MSCs), diabetic wound group with implanted fibrin gel and EPCs (DM + EPCs) and diabetic wound group with implanted fibrin gel and combined MSCs and EPCs (DM + MSCs + EPCs) on day 7 and day 14 are shown. : significant difference compared to the control group. : significant difference compared to the control group. : significant difference compared to the DM group. : significant difference compared to the DM + MSCs + EPCs group.
